Chronic mild hypoxia ameliorates chronic inflammatory activity in myelin oligodendrocyte glycoprotein (MOG) peptide induced experimental autoimmune encephalomyelitis (EAE).
暂无分享,去创建一个
[1] E. Benarroch,et al. Hypoxia-induced mediators and neurologic disease , 2009, Neurology.
[2] L. Zimmerli,et al. Angiogenesis and hypertension: an update , 2009, Journal of Human Hypertension.
[3] F. Piscione,et al. In vivo properties of the proangiogenic peptide QK , 2009, Journal of Translational Medicine.
[4] Peter K Stys,et al. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.
[5] J. LaManna,et al. Brain metabolic adaptations to hypoxia , 2009 .
[6] Michael L. Smith,et al. Intermittent Hypoxia: Cause of or Therapy for Systemic Hypertension? , 2008, Experimental biology and medicine.
[7] J. LaManna,et al. Increased expression of fibronectin and the α5β1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia , 2008, Molecular and Cellular Neuroscience.
[8] J. LaManna,et al. Physiologic angiodynamics in the brain. , 2007, Antioxidants & redox signaling.
[9] J. Rafols,et al. Behavioral pre-conditioning enhances angiogenesis and cognitive outcome after brain trauma , 2007, Neurological research.
[10] Seppo Ylä-Herttuala,et al. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. , 2007, Journal of the American College of Cardiology.
[11] M. Barnett,et al. The pathology of multiple sclerosis: a paradigm shift , 2006, Current opinion in neurology.
[12] J. Rafols,et al. Exercise pre-conditioning strengthens brain microvascular integrity in a rat stroke model , 2006, Neurological research.
[13] G. Hospers,et al. A review on pro- and anti-angiogenic factors as targets of clinical intervention. , 2006, Pharmacological research.
[14] Kui Xu,et al. Chronic hypoxia and the cerebral circulation. , 2006, Journal of applied physiology.
[15] C. Grimm,et al. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration. , 2005, Seminars in cell & developmental biology.
[16] T. Davis,et al. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.
[17] Roland Martin,et al. Immunology of multiple sclerosis. , 2005, Annual review of immunology.
[18] Q Lai,et al. Exercise pre-conditioning reduces brain damage in ischemic rats that may be associated with regional angiogenesis and cellular overexpression of neurotrophin , 2004, Neuroscience.
[19] J. LaManna,et al. Structural and functional adaptation to hypoxia in the rat brain , 2004, Journal of Experimental Biology.
[20] C. Grimm,et al. Constitutive Overexpression of Human Erythropoietin Protects the Mouse Retina against Induced But Not Inherited Retinal Degeneration , 2004, The Journal of Neuroscience.
[21] L. Ye,et al. Therapeutic Angiogenesis Using Vascular Endothelial Growth Factor , 2004, Asian cardiovascular & thoracic annals.
[22] J. Waltenberger. Therapeutic angiogenesis in the heart using peptide growth factors: angiogenesis research entering clinical trials , 1998, Angiogenesis.
[23] N. Chandel,et al. Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[24] Robin J. M. Franklin,et al. Why does remyelination fail in multiple sclerosis? , 2002, Nature Reviews Neuroscience.
[25] Erwin G. Van Meir,et al. Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells , 2001, Gene Therapy.
[26] F. Agani,et al. Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia. , 2000, Journal of applied physiology.
[27] T. Henry. Science, medicine, and the future: Therapeutic angiogenesis , 1999 .
[28] J. LaManna,et al. Endothelial activation following prolonged hypobaric hypoxia. , 1999, Microvascular research.
[29] T. Gustafsson,et al. Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. , 1999, American journal of physiology. Heart and circulatory physiology.
[30] J. Rafols,et al. Recovery phase of acute experimental autoimmune encephalomyelitis in rats corresponds to development of endothelial cell unresponsiveness to interferon gamma activation , 1996, Journal of neuroscience research.
[31] P. Dore‐Duffy,et al. Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis. , 1993, Advances in experimental medicine and biology.